If there is a single industry in our indices that needs pain relief, it is biotechnology and pharmaceuticals. With big pharma's business model deemed past its prime and biotech R&D progressing more slowly than the market had hoped, stocks in the sector have taken turns receiving poundings.

Link to Article

What You Missed: Relief From Pin-Pricking May Be at Hand

A new glucose-monitoring device could relieve those with diabetes from the need to draw blood. By Sam Jaffe

Link to Article

Technologyreview.com

		New Data Presented at EuroPCR Continue to Suggest Safety and Efficacy of the CYPHER® Sirolimus-Eluting Coronary Stent in Complex Patients
		Miami, FL (June 2, 2005) – Data from three studies presented at the 2005 EuroPCR Congress highlighted the continued success of the CYPHER® Sirolimus-eluting Coronary Stent in complex patients, including patients with diabetes and small coronary vessels. Full Details

Healthorbit.ca

In an effort to exert tighter control over the flow of drugs through the supply chain, Purdue Pharma (Stamford, CT) and the drug wholesaler H.D. Smith (Springfield, IL) are implementing a pilot program that uses radio frequency identification (RFID) tags to verify drug authenticity.

Link to Article

Pharmtech.com